Atavistik Bio is a privately-held clinical stage biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs. Our proprietary AMPS⢠platform allows us to rapidly unlock functional cryptic pockets across a broad range of target classes to accelerate the development of groundbreaking medicines. We have rapidly established an emerging pipeline of allosteric therapeutics with the potential to achieve superior efficacy and tolerability profiles by leveraging the power of allostery. Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, Lux Capital, and Regeneron Ventures. We are seeking a strategic and dynamic Principal Scientist with deep expertise in hematologic malignancies in cell and in vivo models, to join our R&D group and work with an enthusiastic team of highly skilled scientists in a fast-paced environment. Reporting to the VP, Head of Biology, this individual will be responsible for leading the biology and translational research strategy for small molecule drug candidates. The ideal candidate will have extensive experience in studying the biology behind hematologic malignancies, drug development, biomarker identification, and the ability to work cross-functionally in a dynamic environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal
Education Level
Ph.D. or professional degree